By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Merrimack Pharmaceuticals Inc. 

101 Binney Street

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-441-1000 Fax: 617-491-1386


Start Up


Dyax  Antibody phage display

Company News
Ipsen (IPN.PA) Agrees to Hire 100 Merrimack (MACK) Employees Under $575 Million Cancer Deal 2/15/2017 6:58:00 AM
Biotech Director at Cambridge's Merrimack (MACK) Arrested for Insider Trading Scheme 2/7/2017 3:39:23 PM
Sanofi (SNY) Exec Jumps Ship to Helm Merrimack (MACK) 1/18/2017 6:03:58 AM
Ipsen (IPN.PA) to Acquire Oncology Assets From Merrimack (MACK) for $575 Million 1/9/2017 1:06:21 PM
Cambridge's Merrimack (MACK) Slashes 80% of Workforce, Sells Off Cancer Drugs in $1.025 Billion Deal 1/9/2017 5:41:24 AM
Merrimack (MACK) Halts Phase II HERMIONE Study for Breast Cancer; Further Plans Revealed in January 12/21/2016 7:00:39 AM
Merrimack (MACK) Reports Third Quarter 2016 Financial Results 11/10/2016 4:45:51 PM
Merrimack (MACK) Announces Timing Of Third Quarter 2016 Investor Conference Call 11/3/2016 11:14:29 AM
Merrimack (MACK) Announces Acceptance For Review Of ANDA Filed By Actavis For Generic Doxorubicin Hydrochloride Liposome Injection (Aka DOXIL) 10/31/2016 6:50:10 AM
Merrimack (MACK) Release: Final Results Of NAPOLI-1 Study Confirm Overall Survival And Progression-Free Survival Benefit For The ONIVYDE Regimen For Patients With Metastatic Pancreatic Cancer 10/11/2016 6:57:29 AM